- Report
- May 2024
- 130 Pages
Global
From €5821EUR$6,499USD£4,962GBP
- Report
- October 2021
- 100 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- April 2023
- 110 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- February 2024
- 114 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- May 2025
- 91 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- April 2023
- 96 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- January 2025
- 132 Pages
Global
From €851EUR$950USD£725GBP
The Epipen is a brand of epinephrine auto-injector used to treat severe allergic reactions, such as anaphylaxis. It is a device that delivers a single dose of epinephrine, a hormone that helps to reduce the symptoms of an allergic reaction. The Epipen is the most widely used epinephrine auto-injector on the market and is available in both adult and pediatric doses. It is used by people with severe allergies to help prevent anaphylaxis, a potentially life-threatening allergic reaction.
The Epipen is part of the larger allergy drug market, which includes a variety of medications and treatments used to treat allergies. These include antihistamines, decongestants, corticosteroids, and immunotherapy. Allergy drugs are used to treat a wide range of allergic reactions, from mild to severe.
The Epipen market is highly competitive, with several companies offering their own versions of the device. These include Mylan, Sanofi, Impax Laboratories, and Teva Pharmaceuticals. Other companies, such as Kaleo and Adamis Pharmaceuticals, have also developed their own epinephrine auto-injectors. Show Less Read more